Olivier Danos
Chief Tech/Sci/R&D Officer presso REGENXBIO INC.
Patrimonio netto: 604 583 $ in data 31/03/2024
Profilo
Olivier Danos is the founder of Lysogene SA, which was founded in 2009.
He held the title of Director at Lysogene SA from 2017 to 2018.
Dr. Danos currently holds multiple positions, including Chairman-Scientific Advisory Board at Firalis SA since 2012, Independent Non-Executive Director at Horama SA since 2021, Director at Profilomic SA since 2016, Director at uniQure France SAS, and Chief Scientific Officer & Senior Vice President at REGENXBIO, Inc. since 2017.
Dr. Danos has previously worked as a Senior Director-Research at Somatix Therapy Corp.
from 1994 to 1996, Director-Gene Therapy Consortium at University College London, Research Director at Centre National de la Recherche Scientifique, Senior Vice President-Cell & Gene Therapy at Biogen, Inc. from 2014 to 2017, President & Founding Member at European Society of Gene & Cell Therapy, Senior VP-Molecular Medicine & Synthetic Biology at Kadmon Pharmaceuticals LLC, and Chief Scientific Officer at Genethon from 1998 to 2005.
Dr. Danos has a graduate degree from the University of Orsay and a doctorate degree from Université Paris Diderot-Paris 7.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
REGENXBIO, INC.
0.06% | 01/04/2024 | 28 694 ( 0.06% ) | 604 583 $ | 31/03/2024 |
Posizioni attive di Olivier Danos
| Società | Posizione | Inizio |
|---|---|---|
| REGENXBIO INC. | Chief Tech/Sci/R&D Officer | 28/03/2017 |
Firalis SA
 Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | Corporate Officer/Principal | - |
Profilomic SA
 Profilomic SA Medical/Nursing ServicesHealth Services Profilomic SA develops software solutions. It provides services in chemical, lipidomic and metabolomic analyses using liquid chromatography coupled to high resolution mass spectrometry. The company is headquartered in Boulogne-Billancourt, France. | Director/Board Member | 27/10/2016 |
Corlieve Therapeutics SAS
 Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France. | Director/Board Member | - |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Director/Board Member | 12/10/2021 |
Precedenti posizioni note di Olivier Danos
| Società | Posizione | Fine |
|---|---|---|
| LYSOGENE | Founder | 01/04/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01/03/2017 |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Chief Tech/Sci/R&D Officer | 01/12/2005 |
Somatix Therapy Corp.
 Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Corporate Officer/Principal | 01/11/1996 |
| ░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░ ░░░░░░░ | ░░░░░░░░░ | - |
Formazione di Olivier Danos
| University of Orsay | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| BIOGEN INC. | Health Technology |
| REGENXBIO INC. | Health Technology |
| LYSOGENE | Commercial Services |
| Aziende private | 10 |
|---|---|
Somatix Therapy Corp.
Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Health Technology |
| Université Paris Diderot-Paris 7 | Consumer Services |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Centre National de la Recherche Scientifique provides scientific research services. The firm engages in the research capable of advancing knowledge and bringing social, cultural, and economic benefits for society. The company was founded in 1939 and is headquartered in Paris, France. | Government |
| European Society of Gene & Cell Therapy | |
Kadmon Pharmaceuticals LLC
 Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kadmon Pharmaceuticals LLC manufactures and distributes pharmaceutical products. The company is headquartered in Warrendale, PA. | Health Technology |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Health Technology |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Health Technology |
Profilomic SA
Profilomic SA Medical/Nursing ServicesHealth Services Profilomic SA develops software solutions. It provides services in chemical, lipidomic and metabolomic analyses using liquid chromatography coupled to high resolution mass spectrometry. The company is headquartered in Boulogne-Billancourt, France. | Health Services |
Corlieve Therapeutics SAS
Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France. | Health Technology |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | Health Technology |
- Borsa valori
- Insiders
- Olivier Danos
